Among the approximately 500,000 people in the United States affected by lupus nephritis each year, most are women. The disease appears in people with systemic lupus erythematosus (SLE).
Aurinia (Victoria, British Columbia) recently launched an educational campaign about lupus nephritis, called ALL IN, to increase support and awareness of the disease. The company’s first offering is a website for patients and families, www.allinforlupusnephritis.com, which provides a community support page, information about lupus nephritis and its management, and other resources. To date, no therapy specifically for lupus nephritis has been approved by the US Food and Drug Administration (FDA).